Richard D. Lin

机构：Vividion Therapeutics (United States) · ORCID：0000-0002-2118-2590

发表论文 4 篇 · 总被引 191 次 · h-index 4

代表论文

• Tobacco mosaic virus delivery of mitoxantrone for cancer therapy (2018 · Nanoscale · 被引 65)
• Natural Mutations in the Receptor Binding Domain of Spike Glycoprotein Determine the Reactivity of Cross-Neutralization between Palm Civet Coronavirus and Severe Acute Respiratory Syndrome Coronavirus (2007 · Journal of Virology · 被引 61)
• Delivery of mitoxantrone using a plant virus-based nanoparticle for the treatment of glioblastomas (2018 · Journal of Materials Chemistry B · 被引 52)
• Covalent inhibitors of the PI3Kα RAS binding domain impair tumor growth driven by RAS and HER2 (2025 · Science · 被引 12)